Pain News and Research

Latest Pain News and Research

Study shows differences in rates of paracetamol-linked acute liver failure among European countries

Study shows differences in rates of paracetamol-linked acute liver failure among European countries

ESSA Pharma reports net loss of $5.9 million for second quarter 2015

ESSA Pharma reports net loss of $5.9 million for second quarter 2015

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Novel survey shows high rates of tattoo-related infection, itching and swelling in New Yorkers

Novel survey shows high rates of tattoo-related infection, itching and swelling in New Yorkers

Charcot foot increasing among diabetics

Charcot foot increasing among diabetics

Study shows how people's expectation of pain affects the experience of pain

Study shows how people's expectation of pain affects the experience of pain

States may not save much money by ending adult dental coverage under Medicaid: Study

States may not save much money by ending adult dental coverage under Medicaid: Study

Mark A. Lumley recognized by BSBS of MI for research on cognitive-behavioral coping skills training

Mark A. Lumley recognized by BSBS of MI for research on cognitive-behavioral coping skills training

Researchers design new model to identify promising candidates for total hip replacement surgery

Researchers design new model to identify promising candidates for total hip replacement surgery

Actavis announces FDA approval of VIBERZI (eluxadoline) for IBS-D treatment

Actavis announces FDA approval of VIBERZI (eluxadoline) for IBS-D treatment

Children's National Health System first in U.S. to treat osteoid osteoma using MR-HIFU method

Children's National Health System first in U.S. to treat osteoid osteoma using MR-HIFU method

Salix Pharmaceuticals receives FDA approval for Xifaxan 550 mg to treat IBS-D in adults

Salix Pharmaceuticals receives FDA approval for Xifaxan 550 mg to treat IBS-D in adults

Not feeling pain due to genetic mutation may not be a blessing

Not feeling pain due to genetic mutation may not be a blessing

Canadian researchers shed light on molecular dynamics of chronic pain

Canadian researchers shed light on molecular dynamics of chronic pain

New stem-cell based therapy provides pain relief, reduces severity of RDEB in children

New stem-cell based therapy provides pain relief, reduces severity of RDEB in children

New investments may enable two Canadian organizations to improve life for people with hearing loss

New investments may enable two Canadian organizations to improve life for people with hearing loss

New Health Union study finds severe impact of rheumatoid arthritis on patients' quality of life

New Health Union study finds severe impact of rheumatoid arthritis on patients' quality of life

Study indicates that arthritis patients may not be taking medication as regularly as prescribed

Study indicates that arthritis patients may not be taking medication as regularly as prescribed

Study reveals how attitudes, beliefs of cancer patients drive complementary and alternative medicine use

Study reveals how attitudes, beliefs of cancer patients drive complementary and alternative medicine use

Clinical Frailty Scale can help predict readmission or death after hospital discharge in older patients

Clinical Frailty Scale can help predict readmission or death after hospital discharge in older patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.